St Jude starts testing bipolar lead for CRT (cardiac resynchronisation therapy) devices
This article was originally published in Clinica
St Jude Medical has started tests of its next-generation left-heart pacing lead for use with its cardiac resynchronisation therapy (CRT) devices for treating heart failure. The QuickSite 1056T bipolar lead, which at 5.5 French is as small in diameter as the firm's approved QuickSite 1056K unipolar lead, incorporates important advances that improve its manoeuvrability and implantation, said the St Paul, Minnesota firm.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.